CClinicalTrials.gg
CompletedNCT02300012Updated May 27, 2022

A Pilot Study to Investigate Biomarkers in Anterior Cruciate Ligament (ACL) Patients and Healthy Controls

An interventional study of Surgeons knowledge of pre-operative PBIs in Rupture of Anterior Cruciate Ligament, sponsored by United Lincolnshire Hospitals NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-27.

Sponsored by United Lincolnshire Hospitals NHS Trust · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Incident rates of ACL rupture are greatest in 16-39 year olds at almost 1 in 1,000.

Performance Based Investigations (PBIs) can be used to evaluate and select correct approaches to patient treatment, and biochemical, biomechanical and physiological biomarkers in other conditions are sensitive in distinguishing between disease state severities, type of injuries and responsiveness to treatment. Despite the measurement sensitivity of PBIs, these are not widely used possibly owing to their focus postoperatively where benefits are less worthwhile.

This study aims to investigate novel biomarkers as performance based investigations (PBIs) to improve surgical and treatment strategies in anterior cruciate ligament (ACL) patients. The objectives are to identify whether biomarkers, collected before and after operations, can: 1) Assist the surgeon in decision making; 2) Lead to improved prognosis; 3) Be used to predict the outcomes of prognosis, and; 4) Correlate with disease signs/ smoking to help further understand ACL injuries.

02

Conditions studied

  • Rupture of Anterior Cruciate Ligament

Browse trials for

Keywords

  • Anterior cruciate ligament
  • Performance based investigations
03

In context

Rupture

557 studies on the registry are indexed under Rupture; 97 are open to participants now.

This study's enrollment of 8 is below the median of 72 across 334 interventional studies indexed under Rupture.

Browse Rupture studies →

Lead sponsor

United Lincolnshire Hospitals NHS Trust is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • unilateral ACL rupture
  • 18 - 45 years old

Exclusion criteria

Exclusion Criteria:

  • combined posterior and ACL rupture
  • multi-ligament instability including medial or lateral collateral ligament injury
  • other lower limb surgery \<3mths
  • current significant acute injury affecting other lower extremity joints, or other relevant neurological or musculoskeletal pathology.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • No intervention
    Operation - No PBI

    Patients requiring operation - baseline PBI data not seen by surgeon

  • Experimental
    Operation - PBI available

    Patients requiring operation - baseline PBI data seen by surgeon pre-operatively

    Procedure: Surgeons knowledge of pre-operative PBIs

  • No intervention
    Non-operation

    Patients with ACL rupture not requiring operation

  • No intervention
    Control

    Healthy age matched volunteers - No operation

Interventions

  • ProcedureSurgeons knowledge of pre-operative PBIs

    Surgeon performing ACL repair will have prior knowledge of patients pre-operative PBIs to inform surgical practice

06

What researchers measure

Primary outcomes

  1. The change in knee varus/valgus from baseline to 6 weeks post-ACL reconstruction, measured when performing a single leg squat.

    Time frame: Baseline, 6 weeks

  2. The change in knee varus/valgus from baseline to 6 months post-ACL reconstruction, measured when performing a single leg squat

    Time frame: Baseline, 6 months

  3. The change in peak vertical ground reaction force from baseline to 6 weeks post-ACL reconstruction, measured when performing a novel isometric task during sitting.

    Time frame: Baseline, 6 weeks

  4. The change in peak vertical ground reaction force from baseline to 6 months post-ACL reconstruction, measured when performing a novel isometric task during sitting.

    Time frame: Baseline, 6 months

  5. The change in anterior-posterior centre of pressure displacement from baseline to 6 weeks post-ACL reconstruction, measured when performing a 10 second standing balance task.

    Time frame: Baseline, 6 weeks

  6. The change in anterior-posterior centre of pressure displacement from baseline to 6 months post-ACL reconstruction, measured when performing a 10 second standing balance task.

    Time frame: Baseline, 6 months

  7. The change in time taken to complete a sit-to-stand task, from baseline to 6 weeks post-ACL reconstruction

    Time frame: Baseline, 6 weeks

  8. The change in time taken to complete a sit-to-stand task, from baseline to 6 months post-ACL reconstruction

    Time frame: Baseline, 6 months

Secondary outcomes

  1. The change in Interleukin-6 obtained from blood samples at baseline to 6 months post-ACL reconstruction

    Time frame: 6 months post-ACL reconstruction

  2. The change in Tegner Activity Score from baseline to 6 months post-ACL reconstruction

    Time frame: 6 months post-ACL reconstruction

  3. The change in Lysholm Knee Scoring Scale from baseline to 6 months post-ACL reconstruction

    Time frame: 6 months post-ACL reconstruction

  4. The change in International Knee Documentation Committee subjective knee evaluation form from baseline to 6 months post-ACL reconstruction

    Time frame: baseline to 6 months post-ACL reconstruction

  5. The difference in bone morphogenetic protein-7 (BMP-7) between smokers and non-smokers who undergo ACL reconstruction

    Time frame: At time of surgery

07

Study locations

1 site
  • United Lincolnshire Hospitals NHS Trust
    Lincoln, Lincolnshire LN2 5QY, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02300012
Lead sponsor
United Lincolnshire Hospitals NHS Trust
Collaborators
University of Lincoln
Responsible party
Sponsor
First posted
Nov 24, 2014
Start date
Jan 5, 2015
Primary completion
May 20, 2022
Completion
May 20, 2022
Last update
May 27, 2022

Study contacts

Prof David Mullineaux, PhD
principal investigator · University of Lincoln

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion